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~ Correlat ions In Pravastatln Treatment Effect 
Between Carotid and Femoral Intima-Medla 
Thickness, and Coronary Artery Stenosls 
Edc de Grcot, J. Wouter Jukema, Aeilko H. Zwinderman, Alexander 
D. Montouban van Swijndregt, Ad J. van Boven, Rob G.A. Ackerst~fl, Anton 
F.W. van der Steen, Ntcofaan Born, Albert V.G. Bruschke, Kong I. Lie. 
REGRESS study group, Utrecht, Netherlands 
The REgression GRowth Evaluation Statin Study (REGRESS) is a two year 
double blind placebo controlled prospective atherosclerosis regression study, 
pdmadly investigating pravastatin treatment effect by means of repeated 
quantitative coronary artsdngraphy (QCA) in a 885 male population with 
anglographicafly proven coronary artery disease. The differences between 
the means of the Mean Coronary ,?-~.=gment Diameter (MSD), and the medians 
of the Minimum Coronary Obstruction Diameter (MOD) showed a significant 
pravasfatin treatment effect (~MSD = 0.04 mm; p = 0.02); 8MOD = 0.06 mm; 
p = 0.001). With a six monthly interval, 255 patients received five B-:'nede 
ultrasound intima-media thickness (IMT) measurements of 16 prespedlied 
carotid and femoral artedal wall segments. Repeated Measurements ANOVA 
of the combined IM'I" data showed a significant pravastatin treatment effect 
on carotid and femoral IMT (p = 0,0024). The coronary and the padpheral 
treatment effects were correlated. 
Results: The treatment effect on IMT (baseline IMT minus IMT dudng 
the iris') was not significantly correlated to the treatment effect on coronary 
diametsr parameters: p > 0.30. 
Conclusion: Pravastatin treatment effect was shown in the coronary arter- 
ies as well as in the carotid and femoral arteries. However, no correlations in 
treatment effect between the coronary and the peripheral artsdes could he 
domoastraled. 
~ Prevalence of  Factor V Leiden Among Women With 
Pulmonary Embol ism or Deep Vein Thrombosis  
During Pregnancy or Oral ContraoBpUve Use 
Denise R. Hirsch, Katdina M. Mikkola, Peter W. Marks, Edward A. Fox, 
Oavid M. Dortman, Bruce M. Ewenstain, Samuel Z. Goldhaber. Brigham 
and Women's Hospital, Harvard Medical School, Boston, MA 
Although Factor V Leiden is associated with an increased risk of venous 
thmmbosts, its frequency has rarely been studied in women with pulmonary 
embolism (PE) or deep venous thrombosis (DVT) during pregnancy, post- 
partum, or oral contraceptive use. Therefore, we determined the prevalence 
of the Factor V Leiden mutation in 50 woman who had suffered prior venous 
thmmboembolism All 50 patients had genetic analysis performed using PCR 
techniques, A functional assay for activated pmtaln C (APC) resistance was 
carded out in women not on anticoagulants at the time of the assay (n = 
30). Ten women (20%) were hetsrozyguus for the mutation (95 CI, 10% to 
34%). Six of these hetsrozygotes (60%) had PE and/or DVT during the first 
trimester, compared with 3 of the 40 women (0%) without he mutation (p = 
0.0009). The functional essay detected APC resistance in 11 (3"/%) of the 
30 women tested, including all 5 hetsrozygutos not on anticoagulants and 
in 6 women with normal Factor V alleles. In this population, the functional 
assay was 100% sensitive and 76% specific for the genetic mutation. During 
pregnancy or oral contraceptive use, functional APC resistance may occur 
in the absence of Factor V Leiden. Both APC resistance and the Factor V 
Leiden mutation appear to be associated with an increased dsk of PE or 
DVT dudug pregnancy or oral contraceptive i,e. The close association be- 
tween first trimester PE and Factor V Leiden suggests that screening for this 
mutation may be warranted, in women at high dsk of PE or DVT who are 
considering becoming pregnant, 
~ ' ~  Proteln C Resistance In Severe Peripheral 
A lheroecleros is  and in Unherslded Myocerdis l  
Infarction 
Felicita Andreotti, Ralmondo De Cdslofaro, Giuseppe Patti, Carol 
C. Shoulders, Sarah E. White, Mary Giifigan, Willy van de Graef, 
Anne Bradshaw, Graham J. Davies, Attillo Mased, Catholic University, 
Rome, #a/y; RPMS, London, UK 
Activated protein C (APC) inhibits coagulation factors V and VIII. APC dis- 
function has been hypothesized in atheroma nd thrombus development, but 
published data are discordant. Analysis of the Arg506- > Gin mutation of 
the factor V gene. held responsible for APC resistance, and the use of cut-off 
values in functional tests may have underestimated APC abnormalities. To 
assess its possible mlo in atherosctemsis and thrombosis, we investigated 
functional APC resistance in pts with severe peflpheral atherosclerosis but 
no previous thrombeembolism (PVD, n = 39, 41-66 yra) or with previous 
unheralded myocardial infarction (MI, n = 41, 34-64 yrs) and in 47 matched 
healthy controls (CTR, 39-67 yts). Pts were < 60 yrs at diagnosis. APC 
resistance was assessed as the ratio o1 aPTT + APC (0.7 mg/L) over aPTr 
without APC - -  a lower ratio indicating reater resistance. No cut-off value 
was used. In no case were plasma protein S levels < 20%-- known to affect 
APC resistance. Plasma fibdnugen and thrombin-antithmmbin III (TAT) levels 
were also measured. Results are medians with interquartiles: 
PVO pts MIt~s CTR 
APC resistance 3.8 (3.2-4.8)" 4.1 (3.5-4.6)** 4.6 (3.9-5.2) 
Rbflnogen, g/L 2.7 (2.5-3.1)" 2.8 (2.5-3.1)o* 2.5 (2.3-2.8) 
TAT, pg/L 4.3 (2.7-10) 3.6 (2.5-6.6) 4.5 (3-9) 
*p < 0.02 and °*p < 0.01 vs CTR. 
NO significant relation was found between APC resistance and fibrinogen 
or TAT. 
Thus, both PVD and MI patients have signif'cantly greater APC resistance 
compared with healthy controls, as assessed by a global functional assay. 
The data suggest that impaired natural antiso~gulation by protein C, in 
addition to raised fihdnogen, may be a dsk factor for athemsclerosis and 
arterial thrombosis. 
~ UI lmsound Guided Closure o f  False Aneurysms by 
Injecting Biodegradable Bovine Collagen 
Sjef M.P.G. Ernst, Egbert T. BOl, Wybren Jaarsma, E. Gijs Mast, 
Maarten-Jan Suttoq0, Frans L Moll1, H.W, Thijs Plokker. 1 Departments of 
Interventional Cardiology and Vascular Surgery; St. Antonius Hospital, 
N/euwege/n, NL 
Although the prevalence of false aneurysma fter artsfial catheterization may 
be diminishing due to smaller devices, opt(realization of the anticoagufation 
and new ctosure devices, it is not to be expected that this complication will 
be eradicated totally in the future. 
Until now it is generally accepted that surgical closure is the treatment of 
choice, when (ultra sound guided) compression has been ineffective. Previ- 
ously we reported on closure of false aneurysma by insertion of long f~reus 
biodegradable bovine collagen plugs into the cavity. The long collagen fibre 
bundles promote the natural coagulation cascade within the false aneurysm. 
Although more than hundred patients with large false aneurysms have been 
treated successfully without complications, the procedure requires consider- 
able skill. On average 10 to 30 collagen plugs have to be inserted through 
a large cat,re (12F) sheath and an additional puncture in the contralateral 
groin is performed for anglographical verifcaUon of the closure. 
To facilitate application of collagen, a hiahly viscous and cohesive pasts 
was developed by suspending the long COllagen fibres in water. This collagen 
paste is injected through a 6F canala into the centre of the aneurysm under 
guidance of duplex scanning. 3 to 6 cc of the cohesive paste is injected into 
the cavity of the false aneurysm. 6 Patients have been treated successfully 
without complications and good results at short-tenn follow up as assessed 
by duplex scanning. 
We conclude that false aneuWsma can be dosed easily and safely by 
injecting a suspension of biodegradable bovine collagen into the aneuwsro 
under duplex guidance. 
~ Elevated Plasma Homecysteine: A Common 
Reversible Risk Factor for  Thromboembol lsm in 
Men and Women 
Anjan Gupta, Kaedice Kottke-Marchant, Mlohelle 3esic, Donald 
W. Jacobsen, Ralph Green, Kill(an Robinson. The Cleve~+nrl C inic 
Foundation, Cleveland, Ohio 
Back qTound: High plasma homocystalne is a dsk factor for atheroscterosis 
but the relationship between homocyeteine and thrombosis in the presence 
of a normal hypemoagulalion profile is unknown. 
Methods: Fasting homocystsine concentrations were determined in 60 
patients (37 men, 23 woman, age 46 ::1:12 yrs) with thmmbesis and were 
compared with healthy age and sex matched controls. All patients had nega- 
tive screening tests for hypercoagulability. The 951h percentile (17.9 mmol/L) 
in controls was taken as a cut point to define a high homocysteine concen- 
tration (HHE). 
Results: Mean homocysteine concentrations were higher in cases than 
controls (21.3 + 13.8 vs 11.0 4. 4.7 mmol/L, p < 0.001). Concentrations were 
higher both in male (22.9 4. 13.6 vs 11.7 + 3.4 mmol/L, p < 0.001) and in 
fer~ats cases (20.1 4.14.2 vs 9.7 :t: 6.2 retool/L, p < 0.01), when compared 
to gender-matched controls. 
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All Cases (n = 60) Male Cases (n = 37) Female Cases (n = 23) 
HHE 51% 40% 60% 
Odds Ratio 9.8* 2.9* 8.2" 
(g0% C;I.) (4.3-24) (1.1--8.2) (2.2-30.7) 
• p < 0.01 cumpamd with conl~ols. 
Conclu,~ions: High ptasm~ homocysteine concentration is a poweffu( risk 
factor for thrombosis in both man and women. Since homocysteine can be 
reduced by B vitamins, a possible therapeutic role for these agents may 
exists in patients with thromboerobolism. 
~ Aceelerated Thrombolysls  Using a New 
Intravascular  Therapeutic Ultrasound Catheter 
Katsuro Tachibena, Shunro Tachibens. Fukuoka University and Wakasugi 
Medical Research Institute, Fukuoka, Japan 
Preclinical expedments were carded out to evaluate the perfOrmance and 
safety of a newly developed catheter, tipped with a ultrasound transducer 
designed to accelerate thrombolysis. Urokinese (UK, 24OIU/rot) was added 
to arliticlal thrembus produced by in vifre Chandler's tubes (diameter 3 taro). 
The roiniature ultrasound (US) emiiting ceramic element (diameter 1 ram) 
mounted at the tip of a 3F catheter was inserted directly inside the tube near 
the artificial throrobus. US (1 MHz) was exposed for a total of 60 sec at an 
intensity of 0.3 W/crib. Fibrinolysis was determined by the percentage of 
weight loss of throrobus after incubation of 15 to 90 minutes. 
Incubation (mini 
15 30 60 go 
UK alone 12 ± 2.4 28 ± 2.6 40 4-1.2 46 :t: 4.6 
UK+US 33±6,1" 44:t:3.3' 56±7.2* 67±1.8" 
n = 5, *Significant difremnses, UK vs UK + US, p < 0.05 
US exposure atone showed no fibrinolysis. 
Ultrasound exposed for durations of 30 minutes with tne same device and 
conditions to normal rabbit (n = 5) abdominal aorla resulted in no significant 
tissue damage (Histological and SEM observations). 
Conclusion: Therapeutic ultrasound emission from the new flexible in- 
travescular catheter accelerated thrombelysis. Clinical application of this 
device for peripheral vascular thrombosis is anticipated. 
~ 7  Silent Pulmonary Embolism in Patients With a 
Permanent lYansvenous Pacemaker 
Tatsuo liD, Jun Tanouchl, MIwa Kitamura, Jun]i Kato, Toshikazu Modoka, 
Mesaroi Nishino, Kunimitsu Iwai, Hldeo Tanabeshi, Yoshio Yameda. Osaka 
Rosai Hospital, Osaka, Japan 
Pulmonary embolism (PE) is a frequently silent but occasionally sedous 
complication of permanent rensvenous p~_cing. To examine the correlation 
between PE and venous route thrombus, age, sex, follow-up interval, type of 
pacaroaker (DDD or VVI), cardiac function and type of arrhythrota in patients 
(pts) with permanent ransvenous pacing, we performed pulmonary perfu- 
sion sclntlgraphy (PPS), digital subtraction angiogrephy (DSA) and trans- 
esophageal echocardiography (TEE) in 42 pts with a pacemaker who did not 
take anticoegulation therapy. The pts ware divided into two groups according 
to the presence of perfuston defect by PPS; 29 pts without paffuslon defect 
(PE-) and 13 pts with parfuslon defect (PE+). Of 36 pts, 15 pts (35,7%) 
coropllcated venous throrobus by DSA and 2 pts (4.8%) complicated right 
atrial thrombus by TEE. 
PE(+) . PSi-) p 
Age 704-12 66 4- 10 n.s. 
Sex (% male) 46.2 51.7 n.s. 
Follow.up Intsrval (ym) 5.3 ± 4.5 5.0 4- 3.2 n.s. 
of pacemaker (% DDD) 38.5 24.1 n.s. 
Ejection fraction (%) 64 ± 12 70 ± 6 n.s. 
Atdal fibrillation (%) 30.8 6.9 <0.05 
Venous route thtembus (%1 78.9 17.2 <0.001 
We conclude atdal fibdllatlon and venous thrombus frequently bring about 
PE in pts with a transvenous pacemaker and suggesting that origin of threm- 
bus causing PE is mainly venous thrombus of upper limb. 
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~ Circadian Variation of Ventrlcular 
Tachyarrhythmlas In Patients With and Without 
Coronary Artery Disease 
Stetfen Behrens0 Christoph Ehlero, Thomas Br0ggeroasn, Wolfgang Ziss, 
Felix Lampe, Dieldch Andresen, Hans-Peter Schutthetss. Free University, 
Berlin, Germany 
Myocardial ischemia has been proposed to be a major mechanism for the 
morning peak of acute myocardial infarction and malignant arthythmlas re- 
sulting in sudden cardiac death. However, little is known about the circadian 
variation of arrhythmies in patients without ischemtc heart disease. The pur- 
pose of this study was to compare the diurnal distribution of life-threatenieg 
venfficular tashyan'hythroias in patients with and without coronary artery 
disease (CAD). 
We studied 159 patients with an implantabte defibrillator (ICO). During 
fol10w-up 87 patients (55%) had spontaneous appropriate shock episodes 
(SE). The underlying heart disease was CAD in 53 patients (61%). Thirtyfour 
patients (39%) had nonlschemic heart disease (dilated cardiomyopathy n 
= 22, arrhythroogenic right ventricle n --- 3, valve replacement n = 4, no 
structural heart disease n = 5)..time distribution (TD) of SE (calculated as 
percentage of SE at 0-6/6-12/12-18/18-24 hours) was determined in all 
patients and in those with and without ischemic heart disease, SE (n = 448; 
mean 5.3 44 7.3) in all patients showed a clear circadian variation (TD of SE 
(%): 18/35/27/20, p < 0.001) with a morning peak. In patients with CAD the 
same dis~bution of SE (n = 289) was observed (TD of SE (%): 14140127/19, 
p < 0.001). However, in patients without ischemic beart disease SE (n = 
159) were evenly dis|dbuted (TD of SE (%): 23/28/27/22, p = 0.8S). If directly 
compared SE were distributed significantly different between both subgroups 
(p = 0.02). 
Patients with CAD exhibit a circadian variation of SE. In contrast, those 
patients without ischemic heart disease demonstrate an even distribution 
of SE. These findings may underline the role of ischemia for the genesis 
of malignant arrhythmlas in ICD patients and may help to develop specific 
therapeutical strategies in this patient population. 
~-~-~ Beneficial Effects of Cardiac Rehabilitation and 
Exercise Training on Autonomic Determinants of 
Risk 
Daniela Lucini 1 Richard V. Milani2 Massimo Pagard 1, Alberto Maltiani 1, 
Cad J. Lavie 2, Joseph P. Murgo =. 1 CNR, Ospedale "L. Sacco ~, Universita 
di Milano, Italy; 20chsner Medical Institutions, New Orleans, LA 
Autonomic nervous system variables including beroreflex and heart rate 
variability have been shown to predict prognosis following major cardiac 
events. Although cardiac rehabilitation and exercise training (CR) reduce 
subsequent major CHD events, the effects of this therapy with standard 
regimens on autonomic variables are not known. Accordingly, we studied 20 
consecutive patients following a major CHD event, beth before and after a 
formal 12-week outpatient, phase II CR program, to determine the effects of 
this therapy on autonomic variables, and compared these results to 8 similar 
CHD patients who did not padictpate in formal CR. A standard medlcat 
regimen for CHD was used in all patients and was not altered during the 
program. Analysis of RR interval and systelic arterial pressure provided a 
measure of heart rate variability (RR interval variance, a 2) and of bororetiex 
gain [by the frequency domain index {cr)]. Results are: 
SAP RR o 2 a 
(mmHg) {mast) (msec 2) {mseP-JmmHg) 
Rahab Entry 1274-16 966 ~: 102 538 :t: 394 6.6:1:0,9 
patients Exit 1234-16 10764-204* 12024-835* 10.44-4.4" 
Control Entry 124:t:10 9614-95 604 d:487 6.64-2.1 
patients Exit 1254- 29 1039 4-105  850 ~ 565 8.8 -I- 8.0 
Data ate expressed as median :1: Semi Inter Quartile. *p < 0.05 EntTy vs Exit (non- 
parametric ANOVA) 
Conclusion:CR resulted in significant improvements in autonomic function, 
including signilicact increases in RR interva/, of its vadecca, and of baroreflex 
gain. These improvements may influence the overall benefits of CR programs 
in the secondary prevention of CHD above and beyond those provided by 
standard medical regimens. 
